Lungpacer News & Media
Stay up to date with the latest breakthroughs,
research, and company milestones
Sort by:
Lungpacer Achieves Commercial Milestone as Leading U.S. Hospital Performs First AeroPace® Procedures to Help Patients Liberate from Mechanical Ventilation
December 8, 2025
Press Release
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
November 4, 2025
Press Release
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
August 14, 2025
Press Release
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System’s Breakthrough Results in Ventilator Weaning
June 12, 2025
Press Release
Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
April 28, 2025
Press Release
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
March 24, 2025
Press Release
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
March 10, 2025
Press Release
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
February 20, 2025
Press Release
Lungpacer Medical Announces Premarket Approval for AeroPace® System
December 5, 2024
Press Release
